Search Results - "Burris 3rd HA"

Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model.

Authors: Jenner, Adrianne L. Kelly, Wayne Dallaston, Michael et al.

Source: PLoS Computational Biology. 1/17/2023, Vol. 19 Issue 1, p1-26. 26p. 6 Diagrams.

Stereotactic body radiation therapy induced myonecrosis in a patient with prior gemcitabine administered for leiomyosarcoma.

Authors: Facer, Benjin D. Dutta, Sunil W. Showalter, Timothy N.

Source: Journal of Radiosurgery & SBRT. 2020, Vol. 7 Issue 1, p77-80. 4p.

Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report.

Authors: Seong Ji Choi Hyo Jung Kim Jae Seon Kim et al.

Source: BMC Cancer. 8/2/2016, Vol. 16, p1-4. 4p. 2 Color Photographs, 2 Black and White Photographs.

The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-positive HER2-negative Non-Metastatic Breast Cancer.

Authors: Etikasari, Ria Andayani, Tri Murti Endarti, Dwi et al.

Source: International Journal of Hematology-Oncology & Stem Cell Research. Jan2023, Vol. 17 Issue 1, p48-55. 8p.

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.

Authors: Wei Wu Heran Deng Nanyan Rao et al.

Source: Trials. 10/25/2017, Vol. 18, p1-6. 6p. 2 Charts.

The advance of adjuvant treatment for triple-negative breast cancer.

Authors: Jingyu Ge Wenjia Zuo Yiyu Chen et al.

Source: Cancer Biology & Medicine. Feb2022, Vol. 19 Issue 2, p187-201. 15p.

MATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLS.

Authors: YILDIZ, TUĞBA AKMAN KÖSE, EMEK ELLIOTT, SAMANTHA L.

Source: Journal of Biological Systems. Dec2021, Vol. 29 Issue 4, p799-822. 24p.

Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?

Authors: Kemp, Robert Prasad, Vinay

Source: BMC Medicine. 07/21/2017, Vol. 15, p1-7. 7p. 2 Charts.

The role of stromal cancer-associated fibroblasts in pancreatic cancer.

Authors: von Ahrens, Dagny Bhagat, Tushar D. Nagrath, Deepak et al.

Source: Journal of Hematology & Oncology. 3/28/2017, Vol. 10, p1-8. 8p.

Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.

Authors: Seung Tae Kim Jeeyun Lee Se Hoon Park et al.

Source: BMC Cancer. 3/23/2017, Vol. 17, p1-6. 6p. 3 Charts, 1 Graph.

MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells.

Authors: Hiroaki Akasaka Yoshiyuki Mizushina Kenji Yoshida et al.

Source: Radiation Oncology. 11/22/2016, Vol. 11, p1-11. 11p.

Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells.

Authors: Yan Zhou Shuchen Lin Kuo-Fu Tseng et al.

Source: BMC Cancer. 10/21/2016, Vol. 16, p1-9. 9p. 1 Chart, 4 Graphs.

Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.

Authors: Lee, Victor Ka-On Lam Kwong, Dora et al.

Source: Journal of Medical Case Reports. 9/7/2016, Vol. 10, p1-4. 4p.

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice.

Authors: De Vita, Ferdinando Ventriglia, Jole Febbraro, Antonio et al.

Source: BMC Cancer. 9/2/2016, Vol. 16, p1-8. 8p. 5 Charts, 5 Graphs.

Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis.

Authors: Katz, D. Azraq, Y. Eleyan, F. et al.

Source: BMC Cancer. 8/8/2016, Vol. 16, p1-8. 8p. 1 Color Photograph, 3 Diagrams, 1 Chart.

Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis.

Authors: Guoqing Ouyang Zhipeng Liu Qianglong Li et al.

Source: World Journal of Surgical Oncology. 2/29/2016, Vol. 14, p1-9. 9p.

Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis.

Authors: Xue-Qin Yang Chong-Yi Li Ming-Fang Xu et al.

Source: BMC Cancer. 12/16/2015, Vol. 15, p1-14. 14p. 2 Diagrams, 7 Charts, 1 Graph.

Efficient “green” encapsulation of a highly hydrophilic anticancer drug in metal–organic framework nanoparticles.

Authors: Rodriguez-Ruiz, Violeta Maksimenko, Andrei Anand, Resmi et al.

Source: Journal of Drug Targeting. Aug-Sep2015, Vol. 23 Issue 7/8, p759-767. 9p.

The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer.

Authors: Mahalingam, Devalingam Patel, Sukeshi Nuovo, Gerard et al.

Source: BMC Cancer. Jul2015, Vol. 15 Issue 1, p1-5. 5p. 1 Color Photograph, 1 Black and White Photograph, 1 Diagram, 1 Graph.

Inhibitory effect of (−)-epigallocatechin-3- gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth.

Authors: Bimonte, Sabrina Leongito, Maddalena Barbieri, Antonio et al.

Source: Infectious Agents & Cancer. Jul2015, Vol. 10 Issue 1, p1-7. 7p. 2 Charts, 3 Graphs.